您的购物车当前为空
CAY10669 is an inhibitor of the histone acetyltransferase PCAF (p300/CREB-binding protein-associated factor; IC50 = 662 μM), displaying a 2-fold improvement in inhibitory potency over anacardic acid . At 30-60 μM, CAY10669 can dose-dependently inhibit histone H4 acetylation in HepG2 cells in vitro.
CAY10669 is an inhibitor of the histone acetyltransferase PCAF (p300/CREB-binding protein-associated factor; IC50 = 662 μM), displaying a 2-fold improvement in inhibitory potency over anacardic acid . At 30-60 μM, CAY10669 can dose-dependently inhibit histone H4 acetylation in HepG2 cells in vitro.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,980 | 35日内发货 | |
| 5 mg | ¥ 8,850 | 35日内发货 | |
| 10 mg | ¥ 15,900 | 35日内发货 |
| 产品描述 | CAY10669 is an inhibitor of the histone acetyltransferase PCAF (p300/CREB-binding protein-associated factor; IC50 = 662 μM), displaying a 2-fold improvement in inhibitory potency over anacardic acid . At 30-60 μM, CAY10669 can dose-dependently inhibit histone H4 acetylation in HepG2 cells in vitro. |
| 靶点活性 | PCAF:662 μM |
| 分子量 | 326.39 |
| 分子式 | C20H22O4 |
| CAS No. | 1243583-88-1 |
| Smiles | C(O)(=O)C1=C(/C=C\C2=CC=C(OCCCCC)C=C2)C=CC=C1O |
| 密度 | 1.192 g/cm3 (Predicted) |
| 存储 | |||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 30 mg/mL (91.91 mM), Sonication is recommended. Ethanol: 30 mg/mL (91.91 mM), Sonication is recommended. DMF: 30 mg/mL (91.91 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO/Ethanol/DMF
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | |||||||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多